POS-831 THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH eGFR <30 mL/min/1.73m2: FINDINGS FROM THE DAPA-CKD TRIAL

POS-831 THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH eGFR <30 mL/min/1.73m2: FINDINGS FROM THE DAPA-CKD TRIAL

Bibliographic Details
Main Authors:	G.M. Chertow, P. Vart, N. Jongs, R.D. Toto, J.L. Gorriz, F.F. Hou, J.J.V. McMurray, R. Correa-Rotter, P. Rossing, C.D. Sjöström, B.V. Stefánsson, A.M. Langkilde, D.C. Wheeler, H. Lambers Heerspink
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024921010159

Similar Items

POS-832 DAPAGLIFLOZIN IN IgA NEPHROPATHY: FINDINGS FROM THE DAPA-CKD TRIAL
by: H. Lambers Heerspink, et al.
Published: (2021-04-01)

Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA‐CKD Trial
by: Glenn M. Chertow, et al.
Published: (2023-05-01)

POS-336 THE IMPACT OF CHRONIC KIDNEY DISEASE AND CLINICAL EVENTS ON PATIENT HEALTH RELATED QUALITY OF LIFE IN DAPA-CKD
by: P. MCEWAN, et al.
Published: (2021-04-01)

IgA Nephropathy with Macroproteinuria and a GFR of 20-30 ml/min/1.73 m May Still Benefit from RAS Inhibition
by: Ying Wang, et al.
Published: (2022-12-01)

Fluid homeostatic action of dapagliflozin in patients with chronic kidney disease: the DAPA-BODY Trial
by: Kentaro Oka, et al.
Published: (2023-12-01)

POS-687 DONOR CYSTATIN C eGFR> 100 ml/min/1.73m2 IS AN INDEPENDENT PREDICTOR OF GRAFT SURVIVAL IN INDIAN KIDNEY TRANSPLANT RECIPIENTS
by: R. ALAM, et al.
Published: (2021-04-01)

Association between 24h Urinary Sodium and Potassium Excretion and Estimated Glomerular Filtration Rate (eGFR) Decline or Death in Patients with Diabetes Mellitus and eGFR More than 30 ml/min/1.73m2.
by: Takanobu Nagata, et al.
Published: (2016-01-01)

Klotho inversely relates with carotid intima- media thickness in atherosclerotic patients with normal renal function (eGFR ≥60 mL/min/1.73m2): a proof-of-concept study
by: Javier Donate-Correa, et al.
Published: (2023-05-01)

Evidence-based Appraisal of the DAPA-HF Trial
by: Anthony Sengul, et al.
Published: (2020-10-01)

The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study
by: Gabriella di Mauro, et al.
Published: (2022-02-01)

Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial
by: Akihiko Koshino, et al.
Published: (2023-11-01)

Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA‐HF Trials
by: Ankeet S. Bhatt, et al.
Published: (2024-03-01)

Early Christian epigraphy, evil, and the apotropaic function of Romans 8.31
by: Strawbridge, J
Published: (2017)

Early Christian epigraphy, evil, and the apotropaic function of Romans 8.31
by: Strawbridge, J
Published: (2017)

Results of the DAPA-CKD trial and their impact on clinical practice
by: O.V. Bilchenko
Published: (2023-06-01)

DAPA-HF trial: dapagliflozin evolves from a glucose-lowering agent to a therapy for heart failure
by: Edgardo Kaplinsky
Published: (2020-02-01)

The DAPA Trial in the Context of Previous Prophylactic ICD Landmark Trials
by: Danielle Haanschoten, et al.
Published: (2021-10-01)

Cavity-enhanced absorption spectroscopy of methane at 1.73 mu m
by: Barry, H, et al.
Published: (2001)

Acute treatment effects on GFR in randomized clinical trials of kidney disease progression
by: Neuen, B, et al.
Published: (2021)

6.831 User Interface Design and Implementation, Fall 2004
by: Miller, Robert
Published: (2004)

Longitudinal estimated GFR trajectories in patients with and without type 2 diabetes and nephropathy
by: Weldegiorgis, M, et al.
Published: (2017)

DAPA-HF study: Are the benefits uniform across non-diabetic subgroups
by: Anil Pareek, et al.
Published: (2020-09-01)

The Y831C Mutation of the <i>POLG</i> Gene in Dementia
by: Eugenia Borgione, et al.
Published: (2023-04-01)

Progress and opportunities in measuring the burden of Chronic Kidney Disease
by: Priya Vart, et al.
Published: (2022-09-01)

The DAPA‐DIET study: Metabolic response to Dapagliflozin combined with dietary carbohydrate restriction in patients with Type 2 Diabetes Mellitus and Obesity—A longitudinal cohort study
by: Petra Hanson, et al.
Published: (2022-11-01)

Towards quadruple therapy for heart failure with reduced ejection fraction: DAPA-HF secondary analysis data
by: Zh. D. Kobalava, et al.
Published: (2020-06-01)

Aerobic and strength training exercise programme for cognitive impairment in people with mild to moderate dementia: the DAPA RCT
by: Lamb, S, et al.
Published: (2018)

SELF-CONSISTENT INTERATOMIC POTENTIALS FOR THE SIMULATION OF BINARY AND TERNARY OXIDES (VOL 4, PG 831, 1994)
by: Bush, T, et al.
Published: (1994)

Presentación 173
by: MARIA FERNANDA ARGUEDAS ABARCA
Published: (2022-07-01)

COLABORADORES 173
by: Revista Ciencias Sociales
Published: (2022-07-01)

DAPA: Differential Analysis aided Power Attack on (Non-) Linear Feedback Shift Registers
by: Siang Meng Sim, et al.
Published: (2020-12-01)

DAPA: Differential Analysis aided Power Attack on (Non-) Linear Feedback Shift Registers
by: Siang Meng Sim, et al.
Published: (2020-12-01)

Searching for the Supermassive Black Hole in NGC 1265 (3C 83.1B)
by: Beifiori, A, et al.
Published: (2010)

Biochemical and mutational analysis of a novel nicotinamidase from Oceanobacillus iheyensis HTE831.
by: Guiomar Sánchez-Carrón, et al.
Published: (2013-01-01)

Urinary Markers of Oxidative Stress Are Associated With Albuminuria But Not GFR Decline
by: Jørgen Schei, et al.
Published: (2018-05-01)

Examining the Impact of China’s Poverty Alleviation on Nighttime Lighting in 831 State-Level Impoverished Counties
by: Yiguo Shen, et al.
Published: (2023-05-01)

OPA1: 516 unique variants and 831 patients registered in an updated centralized Variome database
by: Bastien Le Roux, et al.
Published: (2019-09-01)

Erratum: Self-consistent interatomic potentials for the simulation of binary and ternary oxides (Journal of Materials Chemistry (1994) 4 (831))
by: Bush, T, et al.
Published: (1994)

Short-term changes in klotho and FGF23 in heart failure with reduced ejection fraction—a substudy of the DAPA-VO2 study
by: Carmen Mora-Fernández, et al.
Published: (2023-08-01)

EDITORIAL DYNA 173
by: Jovani Alberto Jiménez Builes
Published: (2012-01-01)